Drug
Verve 102
Verve 102: highest development phase Phase 2, developed by Verve Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Verve Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| VERVE-102 NCT07839936 | Phase 2 | Atherosclerosis |
Latest
No recent events.
Follow Verve 102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.